COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,886 Articles (22,568 medRxiv, 8,318 bioRxiv)

Most recent first Previous |  Page 239: Articles 2381-2390  | Next

Impact of COVID-19 vaccination on symptoms and immune phenotypes in vaccine-naÏve individuals with Long COVID
Grady, C. B., Bhattacharjee, B., Silva, J., Jaycox, J., Lee, L. W., Monteiro, V. S., Sawano, M., Massey, D., Caraballo, C., Gehlhausen, J., Tabachnikova, A., Mao, T., Lucas, C., Pena-Hernandez, M. A., Xu, L., Tzeng, T. J., Takahashi, T., Herrin, J., Guthe, D. B., Akrami, A., Assaf, G., Davis, H., Harris, K., McCorkell, L., Schulz, W., Griffin, D., Wei, H., Ring, A. M., Guan, L., Dela Cruz, C., Iwasaki, A., Krumholz, H.
10.1101/2024.01.11.24300929 — Posted: 2024-01-12
COVID-19 inequalities in England: a mathematical modelling study of transmission risk and clinical vulnerability by socioeconomic status
Goodfellow, L., van Leeuwen, E., Eggo, R. M.
10.1101/2024.01.11.24301159 — Posted: 2024-01-12
Neural Network-Assisted Humanization of COVID-19 Hamster scRNAseq Data Reveals Matching Severity States in Human Disease
Friedrich, V. D., Pennitz, P., Wyler, E., Adler, J. M., Postmus, D., Alves, L. G. T., Prigann, J., Pott, F., Vladimirova, D., Hoefler, T., Goekeri, C., Landthaler, M., Goffinet, C., Saliba, A.-E., Scholz, M., Witzenrath, M., Trimpert, J., Kirsten, H., Nouailles, G.
10.1101/2024.01.11.574849 — Posted: 2024-01-12
SARS-CoV-2 wastewater variant surveillance: pandemic response leveraging FDA's GenomeTrakr network
Timme, R. E., Woods, J., Jones, J. L., Calci, K. R., Rodriguez, R., Barnes, C., Hyde-Leard, E. J., Craven, M., Chen, H., Boerner, C., Grim, C. J., Windsor, A., Ramachandran, P., Muruvanda, T., Rand, H., Tesfaldet, B., Amirzadegan, J., Kayikcioglu, T., Walsky, T., Allard, M. W., Balkey, M., Bias, C. H., Brown, E., Judy, K., Lusk Pfefer, T., Tallent, S. M., Hoffmann, M., Pettengill, J., GenomeTrakr Laboratory Consortium
10.1101/2024.01.10.24301101 — Posted: 2024-01-11
Estimating SARS-CoV-2 transmission parameters between coinciding outbreaks in a university population and the surrounding community
Mietchen, M. S., Clancey, E., McMichael, C., Lofgren, E.
10.1101/2024.01.10.24301116 — Posted: 2024-01-11
Factors that influence-COVID-19 Vaccine Uptake and Hesitancy Among a Population in the West Department of Haiti: Implications for Enhancing Effectiveness of Immunization Programs
Etienne-Mesubi, M., Oni, B., Labbe-Coq, N. R., Alcide-Jean-Pierre, M. C., Lamarre, D., Dorestan, D., Bien-Aime, M.-A., Dorce, V., Freivald, C., Angell, C., Wang, Y., Opoku, J., Shaw, B., Bazira, D.
10.1101/2024.01.10.24301096 — Posted: 2024-01-11
Transient anti-interferon autoantibodies in the airways are associated with efficient recovery from COVID-19
Babcock, B. R., Kosters, A., Eddins, D. J., Donaire, M. S. B., Sarvadhavabhatla, S., Pae, V., Beltran, F., Murray, V. W., Gill, G., Xie, G., Dobosh, B. S., Giacalone, V. D., Tirouvanziam, R. M., Ramonell, R. P., Jenks, S. A., Sanz, I., Lee, F. E.-H., Roan, N. R., Lee, S. A., Ghosn, E. E. B.
10.1101/2024.01.11.24301000 — Posted: 2024-01-11
APNet, an explainable sparse deep learning model to discover differentially active drivers of severe COVID-19
Gavriilidis, G., Vasileiou, V., Dimitsaki, S., Karakatsoulis, G., Giannakakis, A., Pavlopoulos, G., Psomopoulos, F.
10.1101/2024.01.11.575161 — Posted: 2024-01-11
SARS-CoV-2 papain-like protease activates nociceptors to drive sneeze and pain
Mali, S. S., Silva, R., Gong, Z., Cronce, M., Vo, U., Vuong, C., Moayedi, Y., Cox, J. S., Bautista, D. M.
10.1101/2024.01.10.575114 — Posted: 2024-01-11
Protection afforded by post-infection SARS-CoV-2 vaccine doses: a cohort study in Shanghai
Zheng, B., Goncalves, B., Deng, P., Wang, W., Tian, J., Liang, x., Yao, Y., Xue, C.
10.1101/2024.01.09.24301069 — Posted: 2024-01-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).